Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.

Annals of laboratory medicine - 1 Nov 2018

Kim Hyun Young, Lee Ki O, Park Silvia, Jang Jun Ho, Jung Chul Won, Kim Sun Hee, Kim Hee Jin

Abstract excerpt

BACKGROUND: Molecular genetic abnormalities are observed in over 90% of chronic myelomonocytic leukemia (CMML) cases. Recently, several studies have demonstrated the negative prognostic impact of ASXL1 mutations in CMML patients. We evaluated the prognostic impact of ASXL1 mutations and compared five CMML prognostic models in Korean patients with CMML. METHODS: We analyzed data from 36 of 57 patients diagnosed as...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asian People
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Karyotype

Share to Leukemia, Myelomonocytic, Chronic

Share to Prognosis

Share to Repressor Proteins

Share to Republic of Korea

Share to Statistics, Nonparametric

Source

Open in PubMed Open full text

Identifiers

PMID: 30027691
DOI: 10.3343/alm.2018.38.6.495
PMCID: PMC6056400

Genes

ASXL1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Poor Prognostic Implication of ASXL1 Mutations in Korean Patients With Chronic Myelomonocytic Leukemia.PMID 30027691Read ↗

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases.Semantic proximity Read ↗

ASXL1 mutations in myeloid neoplasms: pathogenetic considerations, impact on clinical outcomes and survival.Semantic proximity Read ↗

[Chronic myelomonocytic leukemia (CMML): recent advances in molecular pathogenesis and treatment].Semantic proximity Read ↗

Outcomes and molecular profile of oligomonocytic CMML support its consideration as the first stage in the CMML continuum.Semantic proximity Read ↗

Mutations in chronic myelomonocytic leukemia and their prognostic relevance.Semantic proximity Read ↗

ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patientsSemantic proximity Read ↗

Prognostic score including gene mutations in chronic myelomonocytic leukemia.Semantic proximity Read ↗

Prognostic value of ASXL1 mutations in acute myeloid leukemia: A meta-analysis.Semantic proximity Read ↗

[Clinical Characteristics and Prognosis of Acute Myeloid Leukemia Patients with ASXL1 Gene Mutation].Semantic proximity Read ↗

An international data set for CMML validates prognostic scoring systems and demonstrates a need for novel prognostication strategies.Semantic proximity Read ↗

Frequent ASXL1 mutations in children and young adults with chronic myeloid leukemia.Semantic proximity Read ↗

Prevalence and Prognostic Impact of ASXL1 Somatic Mutation in Patients with Chronic Myeloid Leukemia: A Systemic Review and Meta-AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.